Business Context and Reporting Period
Company: Ingevity Corp (NGVT)
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2025
Business Overview: Ingevity provides products and technologies for automotive emissions control, filtration, asphalt paving, and specialty polymers. The company operates three reportable segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies (APT).
Strategic Shift: The company completed a "Strategic Portfolio Review," resulting in the divestiture of its Industrial Specialties product line and North Charleston crude tall oil (CTO) refinery (completed January 1, 2026). These operations are classified as discontinued. The company is now rebranding as "New Ingevity," focusing on Performance Materials and Pavement Technologies, while exploring strategic alternatives for the APT segment and Road Markings product line.
Key Financial Metrics (2025)
| Metric | 2025 (Continuing Ops) | 2024 (Continuing Ops) |
|---|---|---|
| Net Sales | $1,167.6 million | $1,200.1 million |
| Gross Profit | $461.5 million | $464.8 million |
| Net Income (Loss) | $(167.1) million | $(430.3) million |
| Net Income (Loss) from Continuing Ops | $(150.3) million | $(121.4) million |
| Adjusted EBITDA (Total) | $397.5 million | $362.7 million |
| Cash from Operating Activities | $331.2 million | $128.6 million |
| Total Debt (incl. finance leases) | $1,211.6 million | $1,405.2 million |
| Cash and Cash Equivalents | $78.1 million | $68.0 million |
| Undrawn Credit Facility Capacity | $474.0 million | $302.4 million |
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased 2.7% to $1.17 billion, driven primarily by a 15% volume decline in the Advanced Polymer Technologies (APT) segment due to weak industrial demand and tariff impacts. Performance Materials sales remained flat, while Performance Chemicals sales were flat year-over-year.
- Significant Impairments: The company recorded a $183.8 million non-cash goodwill impairment charge for the APT segment and a $109.3 million long-lived asset impairment charge for the Performance Chemicals road markings asset group.
- Discontinued Operations: Results for the Industrial Specialties product line and CTO refinery are now presented as discontinued operations. The divestiture was completed in January 2026.
- Legal Contingency: The company lost its appeal in the BASF antitrust litigation. A judgment of approximately $85.0 million (trebled damages) plus post-judgment interest (total accrued $95.4 million as of Dec 31, 2025) is expected to be paid in Q2 2026.
- Restructuring: The company incurred $12.8 million in restructuring charges in 2025, part of a broader $370 million program to reposition Performance Chemicals.
Guidance, Outlook, and Risks
2026 Outlook
- Net Sales: Expected between $1.1 billion and $1.2 billion.
- Adjusted EBITDA: Expected between $380 million and $400 million.
- Adjusted EPS: Expected between $4.80 and $5.20.
- Effective Tax Rate: Expected between 22% and 24%.
- Capital Expenditures: Projected at $40 million to $60 million.
Management Commentary
Management emphasizes the transition to "New Ingevity," focusing on high-margin, mission-critical applications in Performance Materials and Pavement Technologies. The company expects to eliminate $15 million in stranded costs from the divested industrial specialties line over the course of 2026.
Key Risks and Contingencies
- Strategic Alternatives: No guarantee that the review of strategic alternatives for APT and Road Markings will result in a transaction or yield expected benefits.
- Legal Liability: Potential additional costs related to the BASF litigation, including attorneys' fees and costs.
- Market Conditions: Exposure to global economic conditions, tariffs, and the shift away from internal combustion engines (ICE) which impacts demand for automotive activated carbon.
- Supply Chain: Dependence on third parties for critical operating services (utilities, wastewater) at key plants in Covington, VA, and Warrington, UK.
Investor Verification Checklist
- BASF Litigation Payment: Verify the timing and total cost of the $95.4 million+ judgment payment expected in Q2 2026, including potential attorney fees.
- Divestiture Closing: Confirm the final financial impact and cash proceeds from the Industrial Specialties/CTO refinery sale completed January 1, 2026.
- Strategic Alternatives Progress: Monitor updates on the potential sale of the APT segment and Road Markings product line, as these are critical to the "New Ingevity" strategy.
- 2026 Guidance Execution: Track performance against the $380-$400 million Adjusted EBITDA guidance, specifically regarding the elimination of stranded costs.
- Debt Covenants: Review compliance with the revolving credit facility covenants (max leverage 4.0x, min interest coverage 3.0x) given the recent impairments and legal liabilities.